CT Financial Advisors’s Novartis NVS Stock Holding History

CT Financial Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$501K	Hold	7,524	–	–	0.31%	88
2016 Q4	$491K	Sell	7,524 -1,392	-16%	-$90.3K	0.31%	83
2016 Q3	$631K	Sell	8,916 -413	-4%	-$30.1K	0.39%	66
2016 Q2	$690K	Sell	9,329 -1,620	-15%	-$112K	0.42%	59
2016 Q1	$711K	Sell	10,949 -736	-6%	-$50.1K	0.4%	62
2015 Q4	$901K	Hold	11,685	–	–	0.52%	53
2015 Q3	$962K	Hold	11,685	–	–	0.6%	47
2015 Q2	$1.03M	Buy	11,685 +15	+0.1%	+$1.38K	0.58%	48
2015 Q1	$1.03M	Sell	11,670 -529	-4%	-$46.9K	0.57%	49
2014 Q4	$1.01M	Buy	+12,199	New	+$1.01M	0.77%	35
2014 Q1	$1.03M	Buy	+11,670	New	+$850K	0.57%	49

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CT Financial Advisors's NVS Position: Q1 2017 in Review

CT Financial Advisors held its Novartis (NVS) position steady in Q1 2017 at 7,524 shares worth $501K. The position accounts for 0.31% of the portfolio, ranked #88.

CT Financial Advisors first reported a position in NVS in Q1 2014 and has held it in 11 quarters since. The position peaked at $1.03M in Q1 2015. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

CT Financial Advisors held 7,524 shares of Novartis worth $501K as of Q1 2017.
CT Financial Advisors left its Novartis share count unchanged in Q1 2017.
Novartis made up 0.31% of CT Financial Advisors's portfolio in Q1 2017, its #88 holding.
CT Financial Advisors first reported a position in Novartis in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's Novartis position peaked at $1.03M in Q1 2015.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.